{
    "Trade/Device Name(s)": [
        "cobas 8000 ISE Indirect Na, K, Cl for Gen. 2"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K123726",
    "Predicate Device Reference 510(k) Number(s)": [
        "K963627",
        "K100853",
        "K053165",
        "K052193"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGS",
        "CEM",
        "CGZ"
    ],
    "Summary Letter Date": "May 21, 2013",
    "Summary Letter Received Date": "April 9, 2013",
    "Submission Date": "November 30, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1665",
        "21 CFR 862.1600",
        "21 CFR 862.1170"
    ],
    "Regulation Name(s)": [
        "Sodium test system",
        "Potassium test system",
        "Chloride test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "cobas 8000 ISE module"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-selective electrode (ISE)",
        "Potentiometric determination"
    ],
    "Methodologies": [
        "Potentiometry"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Reagent",
        "System",
        "Module"
    ],
    "Document Summary": "FDA 510(k) summary for cobas 8000 ISE module and Gen 2 reagents for urine sample type to measure Na, K, Cl using ion-selective electrodes.",
    "Indications for Use Summary": "Automated ion-specific analyzer for in vitro potentiometric determination of chloride, potassium, and sodium in serum, plasma, and urine to aid in diagnosis and treatment of electrolyte imbalance.",
    "fda_folder": "Clinical Chemistry"
}